TechCon SoCal 2026 brought founders, investors, healthcare innovators, enterprise leaders, startup builders, and AI executives to San Diego State University for three days focused on real-world technology adoption.

The event, held May 21–23, showed how AI is moving from technical promise into health innovation, startup investment, regional talent development, enterprise strategy, and practical deployment. For founders, investors, healthcare leaders, marketers, and enterprise teams, the decision is no longer only whether AI can perform a task. It is whether AI-enabled products can earn trust, fit into workflows, attract capital, and create measurable value.

The conference also placed San Diego’s innovation economy in the spotlight. San Diego Mayor Todd Gloria spoke about the region’s strength in life sciences, biotechnology, universities, and technology talent, connecting the event to the local institutions helping prepare the next generation of AI and tech leaders.

In short, TechCon SoCal 2026 showed that AI’s next phase depends on real-world adoption, not technical promise alone. The strongest conversations centered on how startups, healthcare leaders, investors, enterprises, and regional ecosystems can turn innovation into trusted systems people actually use.

TechCon SoCal 2026 was an innovation and investment conference focused on connecting startups, investors, enterprise leaders, and technology builders across AI, healthcare, digital health, consumer technology, SaaS, life sciences, semiconductors, and deep tech.

TechCon SoCal 2026 showed how AI adoption, healthcare innovation, startup capital, regional talent, and enterprise strategy are becoming connected parts of the same technology ecosystem.

TechCon SoCal 2026 was built around the connection between innovation, investment, and adoption. Held at San Diego State University, which TechCon Global described as a Southern California innovation hub, the event brought together leaders across artificial intelligence, SaaS, digital health, life sciences, semiconductors, enterprise systems, and deep tech.

Through panels, startup showcases, curated meetups, hands-on sessions, and networking, the conference created a setting for showcase moments, business investment opportunities, and practical conversations about what it takes for emerging technologies to move from promising ideas into funded, usable, real-world solutions. The conversations were not only about whether AI can perform a task. They were about whether AI-enabled products can solve meaningful problems, earn user trust, attract capital, integrate into existing systems, and scale beyond early adopters.

San Diego Mayor Todd Gloria also spoke at TechCon SoCal 2026, reinforcing the region’s growing role in life sciences, biotechnology, AI, and advanced technology development.

His remarks connected the conference to a larger regional story: San Diego is not only home to major research institutions, universities, biotech companies, startups, investors, and healthcare innovators, but is also working to strengthen the talent pipeline needed to support the next generation of technology companies.

Gloria emphasized the importance of supporting colleges and universities that prepare students for careers in science, technology, entrepreneurship, and AI-driven industries. That message fit closely with TechCon SoCal’s focus on turning innovation into real-world economic and social impact.

For the conference, the mayor’s presence added a civic layer to the discussion, tying individual panels and startup showcases to San Diego’s long-term effort to support innovation, workforce development, and applied technology growth.

The key point: AI and biotech growth depend on more than individual companies. They also depend on universities, public support, regional leadership, workforce development, and local ecosystems that help founders, researchers, students, and investors build what comes next.

Alicia Shapiro, CMO of AiNews.com, moderated the panel “Human-Centered AI: Transforming Health, Access, and the Physical World.” The session focused on how AI is moving beyond productivity and automation to address real-world challenges involving healthcare, accessibility, infrastructure, physical capability, and the built environment.

The panel featured Aadeel Akhtar, Founder and CEO of PSYONIC; Neda Razavi, CEO of iSono Health; Darlene Walley, CEO of NEXT Life Sciences; and David Morczinek, Co-Founder and CEO of AirWorks.

The discussion centered on a practical question: what becomes possible when technology is designed not only to automate work, but to extend human potential, access, and real-world capability?

The panel examined how AI-powered bionics can change the relationship people have with technology and physical ability. It also explored how portable and automated breast imaging could make advanced diagnostics more accessible, especially for people who face fear, discomfort, dense breast tissue challenges, or limited access to traditional screening.

In reproductive health, the conversation addressed how new technology categories may challenge long-standing assumptions about responsibility, family planning, and healthcare adoption. On the infrastructure side, the panel discussed how geospatial AI, imagery, LiDAR, and spatial data can help people understand and manage physical environments at a scale that was previously difficult to achieve.

The key point: human-centered AI depends on adoption, trust, empathy, and real-world usefulness. A system can be technically impressive and still fall short if people cannot access it, understand it, afford it, or trust it in the moments that matter.

Shapiro also moderated “The Next Frontier of Health and Consumer Platforms: AI, Capital, and Scalable Adoption,” a panel focused on how healthcare is changing as AI, consumer technology, data platforms, and capital investment converge.

The panel included Neil Aubuchon, Chief Commercial Officer at Viking Therapeutics; Amir Barsoum, Founder, Managing Partner and CEO of InVitro Capital; and Daniel Oliver, Founder and CEO of Rejuvenate Bio. Howard Lindzon was unfortunately not able to make it to TechCon SoCal this year.

The conversation examined why healthcare innovation is difficult to scale even when the science, technology, or platform model appears promising. Healthcare innovation can only scale when strong technology is matched with trust, accessibility, regulatory alignment, commercialization, workflow fit, patient behavior, and long-term execution.

The panel covered AI-native company building in industries that have historically been difficult to modernize, the path from longevity science and gene therapy into scalable therapies, and the commercialization of next-generation metabolic and obesity treatments. The conversation also explored how consumer-oriented medicine may increasingly involve technology that helps people compare access, pricing, and treatment options.

The healthcare discussion reinforced one of TechCon SoCal’s strongest themes: innovation does not reach people automatically. In health and life sciences, a breakthrough has to move through clinical systems, business models, provider communication, investor timelines, patient trust, and regulatory realities before it can become widely useful.

Shapiro also participated as a panelist in the Women-X-AI Partner Panel, “Rethinking Growth, Talent, and Discovery in the Age of AI.” The session explored how AI is changing company building, investment, productivity, discovery, and the way people manage work and information.

The panel brought together perspectives from founders, investors, and AI media. Ajantha Suriyanarayanan, founder of MentalLoad AI, discussed how founders and business leaders are using AI to improve company operations and reduce the mental burden of managing tasks, schedules, family responsibilities, and professional commitments. Her company helps parents and business leaders “brain dump” into an app that can then act like a virtual assistant, helping users stay organized, manage calendars, and avoid losing track of important responsibilities.

Lolita Taub, an investor, focused on how investors are evaluating AI companies beyond hype. She emphasized that investors are looking for more than companies that use AI as a buzzword. They want to understand whether an AI product solves a real problem, helps people in a meaningful way, and has the potential to create practical, measurable impact.

Shapiro focused on AI visibility and how companies need to prepare for a discovery environment where AI systems influence which brands, experts, products, and sources are cited or recommended. She explained that traditional SEO is largely about being found on a results page, while AI visibility is about being understood well enough to be included inside the answer itself. For companies, that means clear positioning, trustworthy public content, structured explanations, and consistent topical authority are becoming essential to how AI systems classify and recommend them.

The panel’s main takeaway was that AI-era growth is not only about adopting tools. It is about using AI to solve real operational problems, building companies that create human value, and making sure credible businesses can be discovered in the AI systems people increasingly use to make decisions.

The Startup Innovation Showcase gave TechCon SoCal one of its clearest links between emerging technology and investor opportunity. More than 100 startups submitted across AI, healthcare, robotics, sustainability, enterprise software, medtech, and frontier technologies, with seven finalists selected to pitch live before investors, strategic partners, founders, and ecosystem leaders.

The finalist group included Baritone Health, MVI Medical, EZ-Robot, TRII, Hyivy Health, ReRoute Americas, and BioMetal Health. Each company competed for the TechCon Global Winner Trophy and the opportunity to advance to the Startup World Cup Grand Finale in San Francisco, where global startups compete for a $1 million investment prize.

The showcase also included a separate investment opportunity from Emmeline Ventures, which committed $25,000 to one participating company. At TechCon SoCal, MVI Medical received the $25,000 Emmeline Ventures Investment Award in recognition of its healthcare technology and potential real-world impact. Event materials shared with AiNews also identified TRL11 as the TechCon trophy winner advancing to San Francisco for the Startup World Cup opportunity.

For early-stage companies, the showcase demonstrated how pitch competitions can create more than a few minutes on stage. They can give founders investor visibility, ecosystem credibility, partnership conversations, and access to networks that may influence the next stage of company growth.

TechCon SoCal also recognized leaders whose work has shaped technology, healthcare, and entrepreneurship.

Joe Kiani, Founder and Executive Chair of Masimo, received the TechCon Fellows Lifetime Achievement Award. TechCon Global announced Kiani as a recipient in recognition of his work in patient monitoring, healthcare innovation, and patient safety. Kiani also shared after the event that he was honored by the recognition and emphasized that innovation should ultimately serve the purpose of improving people’s lives.

Kiani joined Dr. Irwin Jacobs, co-founder of Qualcomm, who was also named an inaugural TechCon Fellows Lifetime Achievement Award recipient in 2026 for his contributions to wireless technology and innovation.

The awards added a historical layer to the conference by connecting emerging startups and AI-driven companies with leaders whose work has helped shape major technology and healthcare industries over the years.

The most important takeaway from TechCon SoCal 2026 was that AI adoption is becoming a practical systems problem. The technology itself matters, but it is only one part of the story.

Across panels and startup conversations, the same questions kept appearing in different forms. Who can access the technology? Who trusts it? Who pays for it? Who integrates it into workflows? Who is accountable when it affects health, infrastructure, physical ability, investment, or business decisions? Which companies can move from promising demos to real adoption?

That is why the conference felt especially relevant for founders, investors, healthcare leaders, AI companies, marketers, and enterprise teams. Model capability and product announcements are only part of the story. The harder challenge is turning technical progress into tools people trust, workflows they can use, and outcomes that matter.

Q: What was TechCon SoCal 2026 about?
A: TechCon SoCal 2026 was an innovation and investment conference at San Diego State University focused on AI, healthcare, digital health, consumer technology, startup growth, enterprise systems, life sciences, semiconductors, and deep tech. The event connected startups, investors, enterprise leaders, researchers, and technology builders through panels, showcases, networking, and strategic discussions.

Q: How did TechCon SoCal 2026 connect AI innovation to real-world adoption?
A: TechCon SoCal 2026 connected AI innovation to real-world adoption by focusing on the business, human, and operational conditions that determine whether technology reaches users. AI products need more than technical capability. They need trust, workflow fit, accessibility, capital, commercialization, and clear user value before they can scale.

Q: Why did San Diego Mayor Todd Gloria speak at TechCon SoCal 2026?
A: San Diego Mayor Todd Gloria’s remarks connected TechCon SoCal 2026 to the region’s life sciences, biotechnology, university, and technology talent ecosystem. His appearance reinforced the idea that AI and biotech growth depend on local institutions, public leadership, workforce development, and support for colleges preparing future technology leaders.

Q: Why did the healthcare panels matter at TechCon SoCal 2026?
A: The healthcare panels mattered because they showed how AI, biotechnology, diagnostics, reproductive health, bionics, and consumer health platforms are moving into areas where trust and human judgment remain essential. Healthcare innovation can improve access and outcomes, but it must work inside complex clinical, commercial, behavioral, and regulatory systems.

Q: What did Alicia Shapiro discuss on the Women-X-AI panel?
A: Alicia Shapiro discussed AI visibility and how companies need to prepare for a discovery environment where AI systems influence which brands, experts, products, and sources are cited or recommended. The discussion connected AI to growth strategy, marketing, trust, and the changing way people discover information.

Q: What happened during the TechCon SoCal Startup Innovation Showcase?
A: The Startup Innovation Showcase featured seven finalist startups pitching live for investor visibility, the TechCon Global Winner Trophy, and a path to the Startup World Cup Grand Finale in San Francisco. MVI Medical received the $25,000 Emmeline Ventures Investment Award, while event materials shared with AiNews identified TRL11 as the startup advancing to San Francisco for a chance to compete for a $1 million investment prize.

Q: What remains uncertain after TechCon SoCal 2026?
A: TechCon SoCal 2026 showed strong momentum around AI adoption, health innovation, startup investment, and regional technology development, but the longer-term outcomes will depend on what happens after the conference. It remains to be seen which startups secure additional funding, which partnerships lead to deployment, and which AI and healthcare technologies move from promising discussion into measurable real-world use.

TechCon SoCal 2026 showed how quickly AI conversations are moving from possibility to implementation. The practical consequence is that startups, investors, healthcare leaders, marketers, and regional ecosystems now have to focus less on whether AI can produce impressive results in controlled settings and more on what it takes to make those results useful in real organizations.

The key point is that adoption is shaped by the conditions around the technology. Funding, workflow design, trust, regulation, talent pipelines, patient behavior, customer education, and market timing all influence whether an AI-enabled product can move from early interest to lasting use.

Founders should care because the event highlighted how much pressure there is to build products that solve problems people already recognize. Investors should care because the strongest AI companies will need to show credible demand, practical use cases, and a path from product promise to market execution.

Healthcare leaders should care because many of the most important opportunities discussed at TechCon SoCal involved care access, diagnostics, therapies, patient communication, and consumer health platforms. Marketers and business leaders should care because the Women-X-AI discussion showed that AI systems are becoming part of how people discover companies, evaluate expertise, and decide whom to trust.

This matters now because AI is moving into decisions that affect care, infrastructure, business growth, investment, accessibility, and public understanding. As those decisions become more consequential, the cost of weak adoption strategies becomes higher.

The decision for organizations is not simply whether to adopt AI. It is where AI can create real value, where human oversight remains essential, which partners or products are ready for deployment, and how much trust must be built before adoption can scale.

In short, TechCon SoCal 2026 showed that AI adoption is becoming a business, healthcare, investment, and ecosystem challenge at the same time. The companies that succeed will be the ones that connect technical capability with real needs, credible execution, and clear value for the people expected to use it.

The future of AI will belong less to the loudest demonstrations and more to the systems people can trust enough to use.

Reporting note: This article is based on AiNews.com’s firsthand coverage of TechCon SoCal 2026, including Alicia Shapiro’s participation as moderator and panelist, conference sessions, startup showcase information, and event materials shared with AiNews.

Editor’s Note: This article was created by Alicia Shapiro, CMO of AiNews.com, with writing support, AEO/GEO/SEO optimization, image concept development, and editorial structuring support from ChatGPT, an AI assistant. All final editorial decisions, perspectives, and publishing choices were made by Alicia Shapiro.